Intravenous immunoglobulin inhibits staphylococcal toxin-induced human mononuclear phagocyte tumor necrosis factor alpha production.
about
Human antibodies to bacterial superantigens and their ability to inhibit T-cell activation and lethalityBench-to-bedside review: Immunoglobulin therapy for sepsis - biological plausibility from a critical care perspectiveCommercial Intravenous Immunoglobulin (IVIg) Preparations Contain Functional Neutralizing Antibodies Against the Staphylococcus aureus Leukocidin LukAB (LukGH).Combination use of immune complexes and a Ca2(+) channel blocker azelnidipine enhances interleukin-12 p40 secretion without T helper type 17 cytokine secretion in human monocyte-derived dendritic cells.
P2860
Intravenous immunoglobulin inhibits staphylococcal toxin-induced human mononuclear phagocyte tumor necrosis factor alpha production.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Intravenous immunoglobulin inh ...... rosis factor alpha production.
@en
Intravenous immunoglobulin inh ...... rosis factor alpha production.
@nl
type
label
Intravenous immunoglobulin inh ...... rosis factor alpha production.
@en
Intravenous immunoglobulin inh ...... rosis factor alpha production.
@nl
prefLabel
Intravenous immunoglobulin inh ...... rosis factor alpha production.
@en
Intravenous immunoglobulin inh ...... rosis factor alpha production.
@nl
P2093
P2860
P1476
Intravenous immunoglobulin inh ...... rosis factor alpha production.
@en
P2093
Darville T
Laffoon KK
Milligan LB
P2860
P304
P407
P577
1997-02-01T00:00:00Z